Average Distribution: 40.00% (+6.43% 1wk)
- 102 Groups (51.26%) are in the Stage 4 zone (Weak)
- 69 Groups (34.67%) are in the Stage 1 or Stage 3 zone (Neutral)
- 28 Groups (14.07%) are in the Stage 2 zone (Strong)
The IBD Industry Groups Bell Curve increased by +6.43% this week to finish at 40.00% overall.
The amount of groups in Stage 4 (Weak) decreased by 34 (-17%), and the amount of groups in Stage 2 (Strong) increased by 10 (+5%), while the amount groups in Stage 1 or Stage 3 (Neutral) increased by 24 (+12%).
Therefore, the overall distribution of the bell curve continued its rebound from the lower zone, which bottomed at the end of October, and is now on the borderline of the Neutral zone (40% to 60% range). So the weighting has improved and is more neutral, with more stocks moving from Weak (Stage 4) to Neutral (Stage 1 or Stage 3) position, but there is still just over half of the industry groups in the Weak (Stage 4) zone, with less than 40% of their component stocks on point and figure buy signals, and 3.64x as many groups in the Stage 4 zone than Stage 2 zone. However, this is a significant improvement over early October, when this ratio was at 12:1
To compare against the previous blog post: IBD Industry Groups Bell Curve – Bullish Percent (10 November 2023).
Below is the Bell Curve line chart and the data tables of the IBD groups bullish percent in order of relative strength and the position changes over the last 1, 2 and 4 weeks. (Members Only)
Become a Stage Analysis Member:
To see more like this and other premium content, such as the regular US Stocks watchlist, detailed videos and intraday posts, become a Stage Analysis member.
Disclaimer: For educational purpose only. Not investment advice. Seek professional advice from a financial advisor before making any investing decisions.